IGF1 and cancer: It is difficult to identify factors that modulate cancer risk in adults and there is some evidence for in-vitro pro-neoplastic properties and increased serum concentrations of IGF-I that could independently contribute to worse tumor or mortality outcomes in at-risk populations.